Nancy H.

Bellingham, WA

Nancy Shares Testimonial for COPD Treatment at the Lung Institute

Age: 72  |  Location: Bellingham, WA  |  Condition: COPD

Nancy H. was diagnosed with COPD in 2006. The disease hit her hard last winter. She used to walk 6,000 steps a day, but had difficulty even making 500 steps. Her traditional treatments were no longer working. Her husband, a physician, contacted the Lung Institute and after a few conversations they had her first stem cell therapy treatment set up. Right after that treatment she felt she had more energy.

When she got back to her home in Washington she walked up a flight of steps where she had previously had to pull herself up or stop every couple steps to catch her breath. Nancy gives the Lung Institute full credit for her improved health. “They’re bringing me back,” she said.

If you or someone you love has COPD, emphysema, pulmonary fibrosis or another chronic lung disease and would like to learn more about stem cell therapy, contact us at (800) 729-3065.

Are you a candidate? Call (800) 729-3065 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Jerry E.
Kernersville, NC
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.